Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special Issue

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim

Clin Mol Hepatol. 2024;30(suppl):s5-s105. Published online August 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0506

PDF

View: 445 Download: 77

Original Article

Fatigue and weakness hinder patient social reintegration after liver transplantation

So Hyun Kang, YoungRok Choi, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, Sungho Kim, Kil Hwan Kim, In Gun Hyun, Ahmed Shehta

Clin Mol Hepatol. 2018;24(4):402-408. Published online October 8, 2018

DOI: https://doi.org/10.3350/cmh.2018.0028

View: 10377 Download: 116 Web of Science: 11 Crossref: 10

Review

Current status of laparoscopic liver resection for hepatocellular carcinoma

Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Mohan Periyasamy

Clin Mol Hepatol. 2016;22(2):212-218. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2016.0026

View: 13630 Download: 296 Web of Science: 54 Crossref: 51

Management of viral hepatitis in liver transplant recipients

Soung Won Jeong, YoungRok Choi, Jin-Wook Kim

Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.338

View: 8894 Download: 80 Web of Science: 3 Crossref: 3

Original Article

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

Hyeyoung Kim, Nam-Joon Yi, Juyeun Lee, Joohyun Kim, Mi-Ra Moon, Jaehong Jeong, Jeong-Moo Lee, Tae Suk You, Suk-Won Suh, Min-Su Park, YoungRok Choi, Geun Hong, Hae Won Lee, Kwang-Woong Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2014;20(3):291-299. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.291

View: 9901 Download: 98 Web of Science: 6 Crossref: 10

Viewed By 4951	MAFLD: How is it different from NAFLD?
Viewed By 4831	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4740	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4455	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4413	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Author :

Author index